Gossamer Bio (GOSS) Equity Average (2022 - 2025)
Historic Equity Average for Gossamer Bio (GOSS) over the last 4 years, with Q3 2025 value amounting to -$64.2 million.
- Gossamer Bio's Equity Average fell 19467.44% to -$64.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$64.2 million, marking a year-over-year decrease of 19467.44%. This contributed to the annual value of $46.1 million for FY2024, which is 2326.78% up from last year.
- Gossamer Bio's Equity Average amounted to -$64.2 million in Q3 2025, which was down 19467.44% from -$26.2 million recorded in Q2 2025.
- In the past 5 years, Gossamer Bio's Equity Average registered a high of $83.7 million during Q4 2023, and its lowest value of -$64.2 million during Q3 2025.
- Over the past 4 years, Gossamer Bio's median Equity Average value was $20.4 million (recorded in 2022), while the average stood at $17.3 million.
- Its Equity Average has fluctuated over the past 5 years, first tumbled by 76619.94% in 2023, then surged by 64637.65% in 2024.
- Quarter analysis of 4 years shows Gossamer Bio's Equity Average stood at $34.2 million in 2022, then soared by 144.62% to $83.7 million in 2023, then tumbled by 50.04% to $41.8 million in 2024, then crashed by 253.58% to -$64.2 million in 2025.
- Its Equity Average stands at -$64.2 million for Q3 2025, versus -$26.2 million for Q2 2025 and $11.6 million for Q1 2025.